Timothy C. Stonesifer bought $400K of Insulet (PODD)
Executed Jun 3, disclosed Jun 4, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Jun 4), the stock returned +8.7% (delay-adjusted); from the execution session (Jun 3), +13.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
Timothy C. Stonesifer (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Insulet Corporation (PODD). Across 2 priced purchase filings, the average 21-session return was +3.6% from execution and +3.5% from disclosure (delay-adjusted; derived). The largest single filing was $400K of PODD (2,790 sh × $143.51, as filed), executed Jun 3.
Healthcare · Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United Sta…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→962 sh × $311.73
Exec Dec 5 2025
Filed Dec 8 2025 · 4:02 PM ET